CNRL in silico exercise to determine the capabilities of network laboratories to detect triple reassortant swine origin influenza A(H3N2) viruses
Following the emergence of swine influenza A(H3N2) variant (v) viruses with sporadic human infections in North America, the Community Network of Reference Laboratories (CNRL) and the Animal Health and Veterinary Laboratories Agency completed an exercise to assess the CNRL’s capability to detect novel reassortant and circulating triple reassortant swine viruses (TRA) in humans.
Laboratory preparedness in eu/eea countries for detection of novel avian influenza a(H7N9) virus, May 2013
Broberg, E., Pereyaslov, D., Struelens, M., Palm, D., Meijer, A., Ellis, J., Zambon, M., McCauley, J., Daniels, R.
Diagnostic preparedness in Europe for detection of avian influenza A(H7N9) viruses
In China, a novel avian-origin reassortant influenza A(H7N9) virus has been detected in a number of human cases.
Toolkit for investigation of cases of Avian influenza in humans
In order to increase preparedness to respond to possible cases and clusters of Highly Pathogenic Avian Influenza A/H5N1 in humans in Europe, the ECDC has prepared a toolkit for the European Union member states.
Avian Influenza in Cats - ECDC advice for avoiding exposure of humans
Protective measures for humans against avian influenza a(H5N8) outbreaks in 22 European Union/European economic area countries and Israel, 2016–17
Adlhoch, C., Dabrera, G., Penttinen, P., Pebody, R.
Risk assessment: Avian Influenza A/H5N1 in Bathing and Potable (Drinking) Water and Risks to Human Health
Avian influenza: Guidance for National Authorities to Produce Messages for the Public Concerning the Protection of Vulnerable Groups
The document provides some principles to consider when communicating to the public about the public health risks from avian influenza.